Miroslava Hristova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miroslava Hristova has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Penka Atanassova
Department of Neurology, Medical University of Plovdiv, 15A Vasil Aprilov Blvd., 4002 Plovdiv, Bulgaria
2 shared publications - Daniela Kantareva
Department of Nursing Care, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication - Kostadin Kostadinov
Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication - Radka Massaldjieva
Department of Healthcare Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication - Veselina Goranova-Marinova
Department of Hematology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication - Viktoria Babacheva
Department of Hematology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 12 September 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 964
Towards a Neurocognitive Profile of Post-Acute COVID-19: A Longitudinal Study Integrating Subjective Complaints and Computerized Cognitive Testing
Background/Objectives: The relationship between subjective cognitive complaints and objective performance in post-acute COVID syndrome (PACS), and the persistence of objective impairment over extended follow-up, remain unclear. This prospective longitudinal study characterized the neurocognitive profile of PACS by integrating computerized cognitive testing with structured evaluation of subjective complaints across an extended post-infection interval. Methods: A total of 102 adults with a history of COVID-19 infection (3–35 months post-infection; mean age 40.2 ± 10.95 years; 70.6% female) underwent baseline (V1) CogState Battery testing (seven subtests) and structured assessment of persistent post-COVID complaints; 67 participants (65.7%) constituted the matched longitudinal sample and completed the follow-up (V2) after a mean inter-visit interval of 6.69 ± 1.00 months. Domain-specific composites (Attention/Psychomotor function, Learning/Working memory, and two Global indices) were derived from age-adjusted z-scores, with impairment defined as z ≤ −1.5. Results: Persistent complaints were reported by 63.7% of participants at baseline. In the matched longitudinal sample (n = 67) Attention/Psychomotor impairment was the most prevalent and stable finding in the paired sample (65.7% at V1 and 67.2% at V2; McNemar p = 1.000), whereas ONB-defined working-memory impairment declined nominally in the paired sample (39.4% to 24.2%; p = 0.006), although this change did not remain significant after correction for multiple comparisons (BH-FDR q = 0.063). In the baseline sample persistent complaints were associated with poorer objective performance at V1 across all composite indices with small-to-moderate effect sizes (all BH-FDR-adjusted q = 0.042–0.047). These associations were not observed in the follow-up sample at V2. Age was the most robust demographic correlate of impairment, particularly for visuospatial associative memory (CPAL; β = −0.349, p < 0.001); clinical and demographic predictors explained 9.4–13.9% of the variance (R2 = 0.094–0.139) in significant models at Visit 1. Conclusions: Attention/psychomotor dysfunction constituted a persistent objective deficit after COVID-19. Subjective complaints at baseline were associated with objective impairments but did not predict cognitive performance at follow-up. These findings support the use of objective computerized cognitive testing alongside symptom screening in the clinical assessment of post-COVID patients. Interpretation is limited by the absence of pre-COVID cognitive data and of a demographically matched healthy, uninfected control group.
- 12 September 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 964
Open AccessTowards a Neurocognitive Profile of Post-Acute COVID-19: A Longitudinal Study Integrating Subjective Complaints and Computerized Cognitive Testing
Background/Objectives: The relationship between subjective cognitive complaints and objective performance in post-acute COVID syndrome (PACS), and the persistence of objective impairment over extended follow-up, remain unclear. This prospective longitudinal study characterized the neurocognitive profile of PACS by integrating computerized cognitive testing with structured evaluation of subjective complaints across an extended post-infection interval. Methods: A total of 102 adults with a history of COVID-19 infection (3–35 months post-infection; mean age 40.2 ± 10.95 years; 70.6% female) underwent baseline (V1) CogState Battery testing (seven subtests) and structured assessment of persistent post-COVID complaints; 67 participants (65.7%) constituted the matched longitudinal sample and completed the follow-up (V2) after a mean inter-visit interval of 6.69 ± 1.00 months. Domain-specific composites (Attention/Psychomotor function, Learning/Working memory, and two Global indices) were derived from age-adjusted z-scores, with impairment defined as z ≤ −1.5. Results: Persistent complaints were reported by 63.7% of participants at baseline. In the matched longitudinal sample (n = 67) Attention/Psychomotor impairment was the most prevalent and stable finding in the paired sample (65.7% at V1 and 67.2% at V2; McNemar p = 1.000), whereas ONB-defined working-memory impairment declined nominally in the paired sample (39.4% to 24.2%; p = 0.006), although this change did not remain significant after correction for multiple comparisons (BH-FDR q = 0.063). In the baseline sample persistent complaints were associated with poorer objective performance at V1 across all composite indices with small-to-moderate effect sizes (all BH-FDR-adjusted q = 0.042–0.047). These associations were not observed in the follow-up sample at V2. Age was the most robust demographic correlate of impairment, particularly for visuospatial associative memory (CPAL; β = −0.349, p < 0.001); clinical and demographic predictors explained 9.4–13.9% of the variance (R2 = 0.094–0.139) in significant models at Visit 1. Conclusions: Attention/psychomotor dysfunction constituted a persistent objective deficit after COVID-19. Subjective complaints at baseline were associated with objective impairments but did not predict cognitive performance at follow-up. These findings support the use of objective computerized cognitive testing alongside symptom screening in the clinical assessment of post-COVID patients. Interpretation is limited by the absence of pre-COVID cognitive data and of a demographically matched healthy, uninfected control group.
- Open Access
- 22 May 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (6) , 101
Cognitive Performance in Transfusion-Dependent Adults with β-Thalassemia in Bulgaria: A Case–Control Study
Background: As survival improves in transfusion-dependent β-thalassemia, long-term adult morbidity, including cognitive dysfunction, has become increasingly relevant. Adult data remain limited, particularly in Eastern Europe, and many studies rely on single screening tools with limited control for confounding. Methods: We conducted a single-center case–control study (2024–2025) at the Congenital Hemolytic Anemia Treatment Center, University Hospital “Sv. Georgi” Plovdiv, Bulgaria. Fifty adults with transfusion-dependent β-thalassemia (86% thalassemia major; 14% transfusion-dependent intermedia) and 30 frequency-matched healthy controls completed a multi-domain cognitive battery: Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Clock Drawing Test (CDT), Trail Making Test (TMT-A/B), and timed verbal fluency. Associations between thalassemia status and cognitive outcomes were estimated using three prespecified models: unadjusted, adjusted for age and sex, and a doubly robust model combining covariate balancing propensity score inverse probability weighting (balancing BMI, smoking, education, and comorbidity) with age/sex regression adjustment. Results: Patients performed worse than controls on global cognition and executive/visuospatial measures. MoCA scores were lower in patients (−2.26 unadjusted, p = 0.016; −2.83 doubly robust, p = 0.001), as were MMSE scores (−1.64, p = 0.015; −1.87, p = 0.002). CDT performance was consistently poorer (OR ≈ 0.28–0.30 across models). Patients were slower on TMT-B (time ratio 1.35 unadjusted, p = 0.003; 1.42 doubly robust, p < 0.001); TMT-A reached significance only after weighting (ratio 1.32, p = 0.001). Verbal fluency was modestly lower with borderline significance (p ≈ 0.05–0.06). Conclusions: Transfusion-dependent β-thalassemia in adults is associated with poorer cognitive performance, particularly in global cognition and executive/visuospatial domains, with results robust across adjustment strategies. Routine multi-domain cognitive screening may be warranted in adult thalassemia care.
- 22 May 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (6) , 101
Open AccessCognitive Performance in Transfusion-Dependent Adults with β-Thalassemia in Bulgaria: A Case–Control Study
Background: As survival improves in transfusion-dependent β-thalassemia, long-term adult morbidity, including cognitive dysfunction, has become increasingly relevant. Adult data remain limited, particularly in Eastern Europe, and many studies rely on single screening tools with limited control for confounding. Methods: We conducted a single-center case–control study (2024–2025) at the Congenital Hemolytic Anemia Treatment Center, University Hospital “Sv. Georgi” Plovdiv, Bulgaria. Fifty adults with transfusion-dependent β-thalassemia (86% thalassemia major; 14% transfusion-dependent intermedia) and 30 frequency-matched healthy controls completed a multi-domain cognitive battery: Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Clock Drawing Test (CDT), Trail Making Test (TMT-A/B), and timed verbal fluency. Associations between thalassemia status and cognitive outcomes were estimated using three prespecified models: unadjusted, adjusted for age and sex, and a doubly robust model combining covariate balancing propensity score inverse probability weighting (balancing BMI, smoking, education, and comorbidity) with age/sex regression adjustment. Results: Patients performed worse than controls on global cognition and executive/visuospatial measures. MoCA scores were lower in patients (−2.26 unadjusted, p = 0.016; −2.83 doubly robust, p = 0.001), as were MMSE scores (−1.64, p = 0.015; −1.87, p = 0.002). CDT performance was consistently poorer (OR ≈ 0.28–0.30 across models). Patients were slower on TMT-B (time ratio 1.35 unadjusted, p = 0.003; 1.42 doubly robust, p < 0.001); TMT-A reached significance only after weighting (ratio 1.32, p = 0.001). Verbal fluency was modestly lower with borderline significance (p ≈ 0.05–0.06). Conclusions: Transfusion-dependent β-thalassemia in adults is associated with poorer cognitive performance, particularly in global cognition and executive/visuospatial domains, with results robust across adjustment strategies. Routine multi-domain cognitive screening may be warranted in adult thalassemia care.